123 related articles for article (PubMed ID: 2947364)
1. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.
Tufveson G; Odlind B; Sjöberg O; Lindberg A; Gabrielsson J; Lindström B; Lithell H; Selinus I; Tötterman T; Wahlberg J
Transplant Proc; 1986 Dec; 18(6 Suppl 5):16-24. PubMed ID: 2947364
[No Abstract] [Full Text] [Related]
2. Comparison of the in vitro immunosuppressive effects of cyclosporine A and its metabolites.
Copeland KR; Yatscoff RW; Rush D; Jeffery JR
Transplant Proc; 1989 Feb; 21(1 Pt 2):1449-52. PubMed ID: 2523585
[No Abstract] [Full Text] [Related]
3. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
[No Abstract] [Full Text] [Related]
4. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
Freed BM; Rosano TG; Quick C; Lempert N
Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
[No Abstract] [Full Text] [Related]
5. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
Hess AD; Colombani PM
Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
[No Abstract] [Full Text] [Related]
6. Increased risk of rejection in renal transplant recipients with in vitro cyclosporin-resistant lymphoid responses.
Bowes LG; Dumble LJ; Clunie GJ; Francis DM; Macdonald IM; Kincaid-Smith P
Transplant Proc; 1989 Feb; 21(1 Pt 2):1470-1. PubMed ID: 2523587
[No Abstract] [Full Text] [Related]
7. Cyclosporin A.
Morris PJ
Transplantation; 1981 Nov; 32(5):349-54. PubMed ID: 6460358
[No Abstract] [Full Text] [Related]
8. Effect of cyclosporin A on 2ry MLR in patients with progressive systemic sclerosis.
Sabbadini MG; Scorza R; Honorati MC; Coppola C; Vanoli M; Rugarli C; Zanussi C
Boll Ist Sieroter Milan; 1987; 66(6):466-70. PubMed ID: 2968806
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive activity of cyclosporine metabolites in vitro.
Schlitt HJ; Christians U; Wonigeit K; Sewing KF; Pichlmayr R
Transplant Proc; 1987 Oct; 19(5):4248-51. PubMed ID: 2960052
[No Abstract] [Full Text] [Related]
10. Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro.
Beck Y; Akiyama N
Transplant Proc; 1989 Jun; 21(3):3464-7. PubMed ID: 2472695
[No Abstract] [Full Text] [Related]
11. In vitro effects of cyclosporine A on allogeneic and autologous lymphocyte stimulation: influence of HLA phenotypes.
Scorza R; Vanoli M; Cigognini A; Fabio G; De Bernardi B; Zanussi C
Transplant Proc; 1988 Apr; 20(2 Suppl 2):122-4. PubMed ID: 2966475
[No Abstract] [Full Text] [Related]
12. Single-dose response kinetics of cyclosporine.
Bozkurt F; Stierle H; Schollmeyer P; Keller E
Clin Nephrol; 1987 Jul; 28(1):10-4. PubMed ID: 3304744
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cyclosporine A dosage and metabolism in liver and heart transplant recipients.
Hamilton G; Mühlbacher F; Roth E; Wolf I; Piza F; Havel M; Laczkovics A; Schindler J; Wolosczuk W
Transplant Proc; 1987 Feb; 19(1 Pt 2):1706-8. PubMed ID: 3547878
[No Abstract] [Full Text] [Related]
14. Lymphoid resistant responses to in vitro immunosuppression in renal transplant recipients: increased incidence of refractory episodes.
Bowes LG; Dumble LJ; Clunie GJ; Francis DM; Macdonald IM; Kincaid-Smith P
Transplant Proc; 1988 Feb; 20(1):20-2. PubMed ID: 2964112
[No Abstract] [Full Text] [Related]
15. Heterogeneity of dialysis patient lymphocyte responses to cyclosporine.
Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Burdick JF
Transplant Proc; 1996 Aug; 28(4):2063-5. PubMed ID: 8769157
[No Abstract] [Full Text] [Related]
16. Cyclosporine pharmacokinetics and pharmacodynamics after oral administration in the rat.
Didlake RH; Kim EK; Grevel J; Jarolimek L; Kahan BD
Transplant Proc; 1988 Apr; 20(2 Suppl 2):692-5. PubMed ID: 2966483
[No Abstract] [Full Text] [Related]
17. Effect of dietary fat on the pharmacokinetics and pharmacodynamics of cyclosporine in renal transplant recipients.
Tan KK; Trull AK; Uttridge JA; Metcalfe S; Heyes CS; Facey S; Evans D
Transplant Proc; 1994 Oct; 26(5):2955-6. PubMed ID: 7940932
[No Abstract] [Full Text] [Related]
18. Immunopharmacodynamic profiles in renal transplant patients treated intravenously with cyclosporine.
Rogers AJ; Kerman RH; Kahan BD
Transplant Proc; 1984 Dec; 16(6):1634-6. PubMed ID: 6390877
[No Abstract] [Full Text] [Related]
19. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
[No Abstract] [Full Text] [Related]
20. Cyclosporin A metabolites suppress T-cell proliferation by concanavalin A and in a mixed lymphocyte reaction.
Abecassis M; Wong PY; Mason N; Cheung F; Mee AV; Cole EH; Langer B; Cohen Z; Levy GA
Can J Surg; 1988 May; 31(3):145-50. PubMed ID: 2966666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
